Breaking News Instant updates and real-time market news.

AZO

AutoZone

$981.20

1.95 (0.20%)

17:01
03/20/19
03/20
17:01
03/20/19
17:01

AutoZone board authorizes additional $1B stock buyback

AutoZone announced its board authorized the repurchase of an additional $1B of the company's common stock in connection with its ongoing share repurchase program.

  • 26

    Mar

AZO AutoZone
$981.20

1.95 (0.20%)

03/11/19
BOFA
03/11/19
UPGRADE
BOFA
Buy
AutoZone upgraded to Buy from Neutral at BofA/Merrill
03/11/19
BOFA
03/11/19
UPGRADE
Target $1080
BOFA
Buy
BofA/Merrill upgrades AutoZone to Buy on strong fundamentals
As previously reported, BofA analyst Elizabeth Suzuki upgraded AutoZone (AZO) to Buy from Neutral and raised her price target on the stock to $1,080 from $987 as she does not think that the rally for auto parts stocks is over and she believes that AutoZone's valuation discount to the group should narrow as it grows its commercial business. Suzuki also raised her price target on O'Reilly Automotive (ORLY) shares to $415 from $390.
03/11/19
03/11/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Apple (AAPL) upgraded to Buy from Neutral at BofA/Merrill with analyst Wamsi Mohan saying he now sees "stability" of supply chain order cuts and a "large reversal of inventory overhang" in iPhones. He believes negative consensus estimates revisions for fiscal 2020 and 2021 have overshot to the downside and that the valuation, excluding Apple's cash position, is attractive. The analyst also raised his price target for the shares to $210 from $180. 2. Facebook (FB) upgraded to Buy from Neutral at Nomura Instinet with analyst Mark Kelley saying Facebook's transition to Stories appears to be occurring more quickly than we expected. 3. FireEye (FEYE) upgraded to Overweight from Neutral at JPMorgan with analyst Sterling Auty saying the stock's year-to-date performance has been 23% below the group's coverage, and the stock is now trading at 3.7 times estimated fiscal 2019 revenue estimates. 4. Spirit Airlines (SAVE) upgraded to Overweight from Equal Weight at Barclays with analyst Brandon Oglenski raising his price target for the shares to $70 from $65. 5. AutoZone (AZO) upgraded to Buy from Neutral at BofA/Merrill with analyst Elizabeth Suzuki saying she does not think that the rally for auto parts stocks is over and she believes that AutoZone's valuation discount to the group should narrow as it grows its commercial business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/19
EVER
03/20/19
INITIATION
Target $1030
EVER
In Line
AutoZone initiated with an In Line at Evercore ISI
Evercore ISI analyst Greg Melich initiated AutoZone (AZO) with an In Line rating and $1,030 base case price target, stating that he favors the risk-reward at Advance Auto (AAP) with AutoZone shares trading at all-time highs.

TODAY'S FREE FLY STORIES

EBIX

Ebix

$37.16

-3.8 (-9.28%)

11:47
11/12/19
11/12
11:47
11/12/19
11:47
Hot Stocks
Ebix says in final stages of picking investment bank for payments business IPO »

Says "diligently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

11:45
11/12/19
11/12
11:45
11/12/19
11:45
General news
Breaking General news story  »

Richmond Federal Reserve…

11:45
11/12/19
11/12
11:45
11/12/19
11:45
General news
Breaking General news story  »

Richmond Federal Reserve…

BIO

Bio-Rad

$353.49

3.52 (1.01%)

11:39
11/12/19
11/12
11:39
11/12/19
11:39
Hot Stocks
Bio-Rad VP James Stark sells almost $300K in company shares »

Bio-Rad VP James Stark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

11:38
11/12/19
11/12
11:38
11/12/19
11:38
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

11:38
11/12/19
11/12
11:38
11/12/19
11:38
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:37
11/12/19
11/12
11:37
11/12/19
11:37
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

11:37
11/12/19
11/12
11:37
11/12/19
11:37
General news
8-Week Bill Announcement Offering Amount data reported »

8-Week Bill Announcement…

CIEN

Ciena

$38.04

0.26 (0.69%)

11:35
11/12/19
11/12
11:35
11/12/19
11:35
Options
Ciena put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCUL

Ocular Therapeutix

$2.72

-0.205 (-7.01%)

11:25
11/12/19
11/12
11:25
11/12/19
11:25
Recommendations
Ocular Therapeutix analyst commentary  »

Ocular Therapeutix price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

NVTA

Invitae

$16.90

-0.93 (-5.22%)

11:25
11/12/19
11/12
11:25
11/12/19
11:25
Options
Invitae call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHDN

Churchill Downs

$126.44

0.1 (0.08%)

11:25
11/12/19
11/12
11:25
11/12/19
11:25
Hot Stocks
Churchill Downs announces launch of retail sportsbook in Indiana »

Churchill Downs announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$47.20

0.32 (0.68%)

, FGEN

FibroGen

$35.67

0.3 (0.85%)

11:25
11/12/19
11/12
11:25
11/12/19
11:25
Conference/Events
Cowen biotechnology analysts to hold an analyst/industry conference call »

Biotech Analysts Werber…

AZN

AstraZeneca

$47.20

0.32 (0.68%)

FGEN

FibroGen

$35.67

0.3 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 18

    Nov

  • 07

    Dec

ABBV

AbbVie

$87.72

2.08 (2.43%)

11:20
11/12/19
11/12
11:20
11/12/19
11:20
Hot Stocks
AbbVie reports 'positive' data from Phase 2/3 SELECT-AXIS 1 trial »

AbbVie announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

AOBC

American Outdoor Brands

$7.87

-0.29 (-3.55%)

, VSTO

Vista Outdoor

$9.80

-0.1 (-1.01%)

11:17
11/12/19
11/12
11:17
11/12/19
11:17
Hot Stocks
Gunmakers slide as Supreme Court lets Sandy Hook families sue »

The U.S. Supreme Court…

AOBC

American Outdoor Brands

$7.87

-0.29 (-3.55%)

VSTO

Vista Outdoor

$9.80

-0.1 (-1.01%)

RGR

Sturm, Ruger

$44.50

-0.64 (-1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/12/19
11/12
11:17
11/12/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/12/19
11/12
11:16
11/12/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$211.70

3.56 (1.71%)

, AMD

AMD

$36.96

0.66 (1.82%)

11:15
11/12/19
11/12
11:15
11/12/19
11:15
Recommendations
Nvidia, AMD analyst commentary  »

Nvidia price target…

NVDA

Nvidia

$211.70

3.56 (1.71%)

AMD

AMD

$36.96

0.66 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 09

    Dec

AGN

Allergan

$183.63

3.59 (1.99%)

11:15
11/12/19
11/12
11:15
11/12/19
11:15
Options
Allergan put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
11/12/19
11/12
11:15
11/12/19
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
11/12/19
11/12
11:15
11/12/19
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:10
11/12/19
11/12
11:10
11/12/19
11:10
General news
Treasury announced $95 B in 4- and 8-week bill auctions for Thursday »

Treasury announced $95 B…

ESPR

Esperion

$41.00

2.25 (5.81%)

11:09
11/12/19
11/12
11:09
11/12/19
11:09
Hot Stocks
Esperion announces publication of results of Phase 3 study of bempedoic acid »

Esperion announce that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

BA

Boeing

$362.38

-4.59 (-1.25%)

11:05
11/12/19
11/12
11:05
11/12/19
11:05
Hot Stocks
Boeing reports -95 net commercial plane orders through Oct. 31, 2019 »

In an update posted to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

IGT

International Game

$13.18

-0.31 (-2.30%)

11:05
11/12/19
11/12
11:05
11/12/19
11:05
Options
International Game call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.